# Chlorhexidine Vaginal Preparation for Reduction of Post-cesarean Endometritis and Sepsis

> **NCT04385680** · PHASE1,PHASE2 · COMPLETED · sponsor: **Zagazig University** · enrollment: 840 (actual)

## Conditions studied

- Postpartum Endometritis
- Wound Infection
- Chlorhexidine Adverse Reaction
- Postoperative Fever

## Interventions

- **DRUG:** Chlorhexidine Gluconate vaginal solution 0.05%

## Key facts

- **NCT ID:** NCT04385680
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-15
- **Primary completion:** 2022-03-10
- **Final completion:** 2022-08-30
- **Target enrollment:** 840 (ACTUAL)
- **Last updated:** 2022-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04385680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04385680, "Chlorhexidine Vaginal Preparation for Reduction of Post-cesarean Endometritis and Sepsis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04385680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*